Zusammenfassung
Die beiden häufigsten durch Zecken übertragenen Erkrankungen des Nervensystems in Europa sind die Neuroborreliose und die Frühsommer-Meningoenzephalitis (FSME). Abgesehen vom Übertragungsmodus und der Verursachung neurologischer Symptome weisen beide Erkrankungen mehr Unterschiede als Gemeinsamkeiten auf. Die Neuroborreliose ist kausal behandelbar, gegen die FSME kann man sich durch eine Impfung schützen. Die Gesamtprognose ist bei der behandelten Neuroborreliose wesentlich günstiger als bei der FSME.
This is a preview of subscription content, log in via an institution.
Literatur
Benedetti F (2014) Placebo effects: from the neurobiological paradigm to translational implications. Neuron 84(3):623–637
Bernardino AL et al (2008) Toll-like receptors: insights into their possible role in the pathogenesis of Lyme neuroborreliosis. Infect Immun 76(10):4385–4395
Bujak DI et al (1996) Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 23:1392–1397
Bunikis J, Barbour AG (2002) Laboratory testing for suspected Lyme disease. Med Clin North Am 86(2):311–340
Dersch R et al (2014) Efficacy and safety of pharmacological treatments for neuroborreliosis – protocol for a systematic review. Syst Rev 3:117
Dersch R et al (2015) Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis – a systematic review. Eur J Neurol 22(9):1249–1259
Ecker M et al (1999) Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80(Pt 1):179–185
Garin C, Bujadoux C (1922) Paralysie par les tiques. J Med Lyon 71:765–767
Gunther G et al (1997) Tick-borne encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. J Neurol 244(4):230–238
Hemmer B et al (1997) Generalised motor neuron disease as an unusual manifestation of Borrelia burgdorferi infection. J Neurol Neurosurg Psychiatry 63:257–258
Holmgren AR, Matteson EL (2006) Lyme myositis. Arthritis Rheum 54(8):2697–2700
Holzmann H (2003) Diagnosis of tick-borne encephalitis. Vaccine 21(Suppl 1):S36–S40
Kaiser R (1995) Intrathecal immune response in patients with neuroborreliosis: specificity of antibodies for neuronal proteins. J Neurol 242:319–325
Kaiser R (1998) Neuroborreliosis. J Neurol 245:247–255
Kaiser R (1999) The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994–98: a prospective study of 656 patients. Brain 122(Pt 11):2067–2078
Kaiser R (2004) Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone. Nervenarzt 75(6):553–557
Kaiser R (2011) Long-term prognosis of patients with primary myelitic manifestation of tick-borne encephalitis: a trend analysis covering 10 years. Nervenarzt 82(8):1020–1025
Kaiser R, Lucking CH (1993) Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci 118:64–72
Kaiser R et al (1997) Follow-up and prognosis of early summer meningoencephalitis. Nervenarzt 68(4):324–330
Kindstrand E et al (2000) Polyneuropathy in late Lyme borreliosis – a clinical, neurophysiological and morphological description. Acta Neurol Scand 101:47–52
Kohler J, Thoden U (1987) Pain syndromes in tick-borne neuroborreliosis. Clinical aspects and differential diagnosis. Schmerz 1(2):107–113
Kruger H et al (1989) Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years. J Neurol 236:322–328
Leite LM et al (2011) Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study. Inflammopharmacology 19(2):99–110
Muller-Felber W et al (1993) Myositis in Lyme borreliosis: an immunohistochemical study of seven patients. J Neurol Sci 118:207–212
Mygland A et al (2006) Chronic polyneuropathy and Lyme disease. Eur J Neurol 13(11):1213–1215
Nieman GF, Zerler BR (2001) A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury. Curr Med Chem 8(3):317–325
Reik L (1991) Lyme disease and the nervous system. Thieme Medical Publishers, New York
Reik L et al (1985) Demyelinating encephalopathy in Lyme disease. Neurology 35:267–269
Rupprecht TA et al (2008a) Autoimmune-mediated polyneuropathy triggered by borrelial infection? Muscle Nerve 37(6):781–785
Rupprecht TA et al (2008b) The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol Med 14(3–4):205–212
Rupprecht TA et al (2014) CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine. Nervenarzt 85(4):459–464
Stanek G, Reiter M (2011) The expanding Lyme Borrelia complex – clinical significance of genomic species? Clin Microbiol Infect 17(4):487–493
Tikka T et al (2001) Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation. J Neurochem 78(6):1409–1414
Wormser GP (2006) Clinical practice. Early Lyme disease. N Engl J Med 354(26):2794–2801
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Kaiser, R. (2018). Neuroborreliose und FSME. In: Berlit, P. (eds) Klinische Neurologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44768-0_101-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-44768-0_101-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44768-0
Online ISBN: 978-3-662-44768-0
eBook Packages: Springer Referenz Medizin